Xortx announces new proof of concept data in autosomal dominant polycystic kidney disease (adpkd)

Independent study shows moderate dose strength of xorlo™ attenuates kidney expansion independent study shows moderate dose strength of xorlo™ attenuates kidney expansion

XRTX Ratings Summary

XRTX Quant Ranking